Case Study Spotlight: Back in 2017, we embarked on an exciting journey with Zanoprima Lifesciences Ltd, UK, to develop an innovative imine reductase (IRED) catalyzed process for producing (S)-Nicotine.
Our team:
✅ Developed a highly efficient biocatalyst
✅ Optimized the biocatalytic process for chiral intermediate production
✅ Supported scale-up to commercial production
The result? Synthetic nicotine is now on the market, offering significant environmental benefits.
Compared to tobacco-derived nicotine, synthetic nicotine:
🌍 Emits up to 12 times fewer greenhouse gases
💧 Uses significantly less water
More info on the Carbon and Water Footprints of Tobacco-Based vs. Synthetic Nicotine: https://static1.squarespace.com/static/60871c85fd6297141367d5f2/t/65f28926fea3cc5f7dc3a06d/1710393642990/ESG+1+Zanoprima+nicotine+carbon-water+footprint+report_Feb+2024.pdf
